In this on-demand webinar for specialists, hear from three leading Australian specialists as they discuss their views and insights around the use of biosimilar medicines
By the end of this course, participants should be able to:
- Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines
- Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system
- Outline clinical trial data which relate to switching/multiple switching between reference medicine and biosimilar medicine.
This education has been designed for the RACP CPD Program for the 2023-25 triennium. Upon completion of this activity you may claim 1 hour of Category 1 Educational Activity learning in the RACP’s MyCPD programme or Category 4 Self-guided Learning in the RANZCP CPD Program.
Other healthcare professionals can still enrol and complete this course. You will receive a certificate upon completion.
If you do not already have an account with Arterial Education, you will be required to create one. This verifies that you are a healthcare professional and allows you to log your learning activities.